MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000535267

Медицинская библиотека · Oncology research and treatment · 2023

COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome.

Rüthrich Maria Madeleine, Khodamoradi Yascha, Lanznaster Julia, Stecher Melanie, Tometten Lukas, Voit Florian, Koll Carolin E M, Borgmann Stefan, Vehreschild Jörg Janne, Ole Jensen Björn-Erik, Hanses Frank, Giessen-Jung Clemens, Wille Kai, von Lilienfeld-Toal Marie, Beutel Gernot, LEOSS Study Group

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Active malignancies have been identified as an independent risk factor for severity and mortality in COVID-19. However, direct comparisons between SARS-CoV-2-infected patients with active (acP) and non-active cancers (n-acP) remain scarce.

PATIENTS AND

METHODS

We retrospectively analyzed a cohort of cancer patients with PCR-confirmed SARS-CoV-2 infection, enrolled from March 16, 2020, to July 31, 2021. Data on demographics, cancer, and laboratory findings were collected. Descriptive and subsequent regression analyses were performed. Endpoints were "deterioration to severe COVID-19" and "infection-associated mortality."

RESULTS

In total, 987 cancer patients (510 acP vs. 477 n-acP) were included in our analysis. The majority was >55 years old, more men than women were included. At detection of SARS-CoV-2, 65.5% of patients had mild/moderate symptoms, while deterioration to severe COVID-19 was slightly more common in acP (19 vs. 16%; p = 0.284). COVID-19-associated mortality was significantly higher in acP (24 vs. 17.5%, p < 0.001). In terms of laboratory tests, severe cytopenia and elevated levels of inflammatory markers were common findings in acP at baseline, particularly in those who developed a severe infection or died. Multivariate analysis revealed that ferritin (HR 14.24 [2.1-96], p = 0.006) and CRP (HR 2.85 [1.02-8.02], p = 0.046) were associated with severity and mortality. In n-acP, association was seen for ferritin only (HR 4.1 [1.51-11.17], p = 0.006).

CONCLUSION

Comparing patients with active and non-active cancer, the former showed higher mortality rates. Also, inflammatory markers were significantly increased, assuming higher levels of inflammation may play a role in the adverse outcome of COVID-19 in aCP.

Для цитирования: Rüthrich Maria Madeleine, Khodamoradi Yascha, Lanznaster Julia, Stecher Melanie, Tometten Lukas, Voit Florian, Koll Carolin E M, Borgmann Stefan, Vehreschild Jörg Janne, Ole Jensen Björn-Erik, Hanses Frank, Giessen-Jung Clemens, Wille Kai, von Lilienfeld-Toal Marie, Beutel Gernot, LEOSS Study Group. COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome.. Oncology research and treatment. 2023. DOI: 10.1159/000535267.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.